Search results for "From ACP Internist Weekly"
About one-third of Americans with HCV had evidence of viral clearance in past decade
The highest proportion of hepatitis C virus (HCV) cure or clearance among all age groups and payers was 49% among commercially insured patients ages 60 years and older, a study found.
https://gastroenterology.acponline.org/archives/2023/07/28/6.htm
28 Jul 2023
Interval cancer after screening colonoscopy more common in black patients than in white patients
Adjusting for the physicians' detection rate did not alter the differences in risk associated with race/ethnicity, the study noted.
https://gastroenterology.acponline.org/archives/2017/05/26/8.htm
26 May 2017
Phentermine-topiramate most effective drug for weight loss, meta-analysis finds
Among glucagon-like peptide-1 receptor agonists, semaglutide appeared to be the most effective for weight loss, with a higher likelihood of weight loss of 5% or more and percentage body weight change and a similar risk of adverse events.
https://gastroenterology.acponline.org/archives/2021/12/17/7.htm
17 Dec 2021
Flexible sigmoidoscopy associated with long-term reduction in colorectal cancer incidence, mortality
Colorectal cancer incidence and mortality were reduced by about 20% in patients who were randomized to receive once-only flexible sigmoidoscopy screening between the ages of 55 to 64 years instead of usual care.
https://gastroenterology.acponline.org/archives/2021/11/19/6.htm
19 Nov 2021
Recurrent C. difficile infections more than doubled between 2001 and 2012
Risk factors for recurrence include age; sex; and use of antibiotics, proton-pump inhibitors, or corticosteroids. These factors could adjust treatment algorithms for high-risk patients, including earlier use of fecal transplant.
https://gastroenterology.acponline.org/archives/2017/07/28/7.htm
28 Jul 2017
Colonoscopies often recommended to patients with limited life expectancy
A study of patients ages 65 years and older found that 58.1% of those with life expectancy of less than five years and no polyps or only small hyperplastic polyps were told to return for future surveillance, as were 74.8% of those with life expectancy of five to 10 years.
https://gastroenterology.acponline.org/archives/2023/03/24/7.htm
24 Mar 2023
Guidelines update management of eosinophilic esophagitis
Recommendations from the American Gastroenterological Association and the Joint Task Force for Allergy-Immunology Practice Parameters cover use of proton-pump inhibitors, steroids, diets, and endoscopic dilation.
https://gastroenterology.acponline.org/archives/2020/05/22/6.htm
22 May 2020
Response to linaclotide for IBS constipation can still appear after four weeks
An industry-funded analysis of four randomized trials of linaclotide for irritable bowel syndrome (IBS) with constipation found that improvement in abdominal and bowel symptoms occurred after four weeks of treatment in 1 in 6 and 1 in 10 patients, respectively.
https://gastroenterology.acponline.org/archives/2022/12/23/6.htm
23 Dec 2022
Apixaban associated with lower risk of GI bleeding compared to other DOACs
Apixaban users experienced similar rates of ischemic stroke or systemic embolism, intracranial hemorrhage, and all-cause mortality as patients taking other direct oral anticoagulants (DOACs), a retrospective analysis found.
https://gastroenterology.acponline.org/archives/2022/11/18/6.htm
18 Nov 2022
USPSTF expands hepatitis C screening recommendation to most adults
All adults ages 18 to 79 years should now be screened at least once, but people who use injection drugs and pregnant women may require screening more often.
https://gastroenterology.acponline.org/archives/2020/03/27/6.htm
27 Mar 2020